|
Tm |
Dr. Martin R.
Aidelbaum Inc.
|
|
dhtml
|
During normal tooth development a highly specialized protein
matrix provides the natural interface between the mineralizing root dentine and cells
forming a cellular cementum.
BIORA AB was established in 1986 in Malmö, Sweden, to explore and develop a purified
matrix as a new surgical aid in regenerative periodontal surgery.
The product, Enamel Matrix Derivative (EMD), trade name EMDOGAIN, is applied in gel form
to achieve biological regeneration of lost tooth attachment due to periodontal disease Emdogain WT is being designed for use during complicated wisdom
tooth extractions to eliminate or reduce periodontal lesions that typically afflict
neighboring teeth. Based on industry statistics, there are approximately ten million
complicated tooth extractions performed annually in the US. Biora estimates that at least
half of these procedures could potentially benefit from the application of Emdogain WT. .
|
|